BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7528567)

  • 1. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells.
    Sawada K; Sato N; Notoya A; Tarumi T; Hirayama S; Takano H; Koizumi K; Yasukouchi T; Yamaguchi M; Koike T
    Blood; 1995 Jan; 85(1):194-202. PubMed ID: 7528567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.
    Sawada K; Ieko M; Notoya A; Tarumi T; Koizumi K; Kitayama S; Nishio H; Fukada Y; Yasukouchi T; Yamaguchi M; Katoh S; Koike T
    Blood; 1996 Jul; 88(1):319-27. PubMed ID: 8704190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
    Sawada K; Sato N; Tarumi T; Sakai N; Koizumi K; Sakurama S; Ieko M; Yasukouchi T; Koyanagawa Y; Yamaguchi M
    Br J Haematol; 1993 Mar; 83(3):349-58. PubMed ID: 7683482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: II. Response to combined colony-stimulating factors.
    Sawada K; Sato N; Notoya A; Tarumi T; Yasukouchi T; Yamaguchi M; Kohno M; Mikuni C; Koike T
    Eur J Haematol; 1995 Feb; 54(2):85-94. PubMed ID: 7535245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
    Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
    Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
    Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
    Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
    Xie W; Wang X; Du W; Liu W; Qin X; Huang S
    Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
    Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
    Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation and differentiation of myelodysplastic CD34+ cells.
    Sawada K
    Leuk Lymphoma; 1996 Jun; 22(1-2):43-51. PubMed ID: 8724527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells.
    Olweus J; Lund-Johansen F; Terstappen LW
    Blood; 1995 May; 85(9):2402-13. PubMed ID: 7537112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes.
    Delforge M; Demuynck H; Vandenberghe P; Verhoef G; Zachée P; van Duppen V; Marijnen P; Van den Berghe H; Boogaerts MA
    Blood; 1995 Nov; 86(10):3660-7. PubMed ID: 7579331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
    Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G
    Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.